Gerresheimer Regensburg GmbH

Company

    • Company type:
      • Service Provider
    • Year founded:
    • 1948
    • Employees (at the site):
    • not available
    • Turnover range:
    • >=125m EUR
    • Products/services:
    • Gerresheimer Wilden Group is an international acting development partner and injection molder for medical plastic systems. As a full service supplier, Gerresheimer Wilden is your partner for all production stages. From the first product concept to the delivery of the initial plastic component, to the complex assembly, or to the ready-for-sale product, we perform all services: Product development, engineering, moldmaking, automation engineering, large-series and small-series production in clean rooms under FDA/GMP conditions, product refinement, manual, partly automated and fully automated assembly as well as packaging and logistics.

    • Core competencies:
    • Multi-component injection molding, Insert molding, Turning stack mold technology, water injection and internal gas pressure, sandwich technology, Injection embossing, In-mold decoration, Thin-wall injection molding, Micro injection molding, clean-room production, the combination of plastics and metal for canulas for implants, needles for lancets or springs for diving elements in systems, technically demanding products made of several plastic components.

    • Language skills:
    • Chinese
      English
      German
      Portuguese
      Russian
      Spanish
    • Key Tech / section:
      • Mechanical Engineering Industry: Plastics and rubber machinery
      • Mechanical Engineering Industry: Plastics processing and die casting
      • New Materials: Plastics
    • Industries NACE:
      • 22.22: Manufacture of plastic packing goods
      • 22: Manufacture of rubber and plastic products
      • 22.2: Manufacture of plastics products
      • 22.29: Manufacture of other plastic products
    • Certification:
    • DIN EN ISO 14001:2005
      DIN EN ISO 9001:2000
      DIN EN ISO 13485
      FDA Guidelines
      21 CFR Part 11
      Abfüllerlaubnis für klinische Textmuster
      FDA-Inspektion ohne Observation für die Herstellung eines Medizinproduktes mit direktem Blutkontakt

    • Sales markets - target industries:
    • Pharma, Diagnostik, Medizintechnik
    • Sales markets - target countries:
    • not available
    • Cooperation offers:
    • not available
    • Contact person:
    • Uwe Röhrhoff (Mr.)
      - Management

      Andreas Schütte (Mr.)
      - Management

      Karin Strasser (Mrs.)
      - Sales / marketing
      - Cooperation